DAB2 and cancer: In conjunction with the overproduction of TGF-β in tumor cells [27], the loss of Dab2 expression and subsequent impairment of receptor-dependent TGF-β depletion may contribute to the accumulation of TGF-β in the microenvironment, a scenario that correlates with poor prognosis of cancer patients.